Stay updated on Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Sign up to get notified when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.

Latest updates to the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer version label updates from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a minor site release without changing the study record content.SummaryDifference0.1%

- Check8 days agoChange DetectedThe revision label was updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedNo content additions or deletions were observed; the screenshots appear to show only cosmetic/UI layout differences.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page. No study details or eligibility information appear to be changed.SummaryDifference0.1%

- Check51 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3 in the page header/footer.SummaryDifference0.2%

- Check59 days agoChange DetectedA non-essential overlay appears on the study details page, partially obscuring content but not altering core information or navigation.SummaryDifference0.1%

Stay in the know with updates to Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.